BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37447155)

  • 1. Association between the Preoperative Dietary Antioxidant Index and Postoperative Quality of Life in Patients with Esophageal Squamous Cell Carcinoma: A Prospective Study Based on the TTD Model.
    Zhang J; Zhou J; Huang Y; Lin Z; Zhang S; Qiu M; Xiang Z; Hu Z
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of preoperative albumin-to-globulin ratio on overall survival and quality of life in esophageal cell squamous carcinoma patients: a prospective cohort study.
    Zhang J; Lin Z; Zhou J; Huang Y; Chen S; Deng Y; Qiu M; Chen Y; Hu Z
    BMC Cancer; 2023 Apr; 23(1):342. PubMed ID: 37055773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life and treatment modality among esophageal squamous cell carcinoma survivors: A prospective study using time to deterioration model analysis.
    Liu S; Lin Z; Lin J; Chen H; Xie Q; Rao W; Chen Y; Yu K; Hu Z
    J Surg Oncol; 2021 Jan; 123(1):156-163. PubMed ID: 33126290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of postoperative quality of life in patients with esophageal squamous cell carcinoma: does tea consumption have a role?
    Zhang J; Liu S; Song J; Zhou J; Zeng Q; Lin Z; Yu K; Zhang S; Qiu M; Chen Y; Hu Z
    BMC Public Health; 2022 Nov; 22(1):2165. PubMed ID: 36424573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma.
    Wang L; Wang C; Wang J; Huang X; Cheng Y
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):2077-2086. PubMed ID: 28601935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal analysis of quality of life in primary lung cancer patients with chlamydia pneumoniae infection: a time-to-deterioration model.
    Chen Z; Zhuang J; Liu M; Xu X; Liu Y; Yang S; Xie J; Lin N; Lai F; He F
    BMC Pulm Med; 2024 Jan; 24(1):36. PubMed ID: 38233781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacts of treatments on the quality of life among esophageal squamous cell carcinoma patients.
    Chen CY; Hsieh VC; Chang CH; Chen PR; Liang WM; Pan SC; Shieh SH
    Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between physical activity and health-related quality of life: time to deterioration model analysis in lung adenocarcinoma.
    Zhuang J; Liu Y; Xu X; Cai Y; Liu M; Chen Z; Yang S; Lin J; Hu Z; Kang M; Lin M; He F
    J Cancer Surviv; 2023 Dec; 17(6):1769-1779. PubMed ID: 36192668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of life.
    Van Cutsem E; Kato K; Ajani J; Shen L; Xia T; Ding N; Zhan L; Barnes G; Kim SB
    ESMO Open; 2022 Aug; 7(4):100517. PubMed ID: 35785595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary intake of minerals and risk of esophageal squamous cell carcinoma: results from the Golestan Cohort Study.
    Hashemian M; Poustchi H; Abnet CC; Boffetta P; Dawsey SM; Brennan PJ; Pharoah P; Etemadi A; Kamangar F; Sharafkhah M; Hekmatdoost A; Malekzadeh R
    Am J Clin Nutr; 2015 Jul; 102(1):102-8. PubMed ID: 26016858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the prognostic influencing factors of esophageal squamous cell carcinoma and the predictive value of inflammatory reaction indexes on its postoperative recurrence].
    Wang X; Wang Z; Lu WL; Zhao GF
    Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):160-164. PubMed ID: 36781237
    [No Abstract]   [Full Text] [Related]  

  • 12. Higher glycemic index and glycemic load diet is associated with increased risk of esophageal squamous cell carcinoma: a case-control study.
    Eslamian G; Jessri M; Hajizadeh B; Ibiebele TI; Rashidkhani B
    Nutr Res; 2013 Sep; 33(9):719-25. PubMed ID: 24034571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181.
    Adenis A; Kulkarni AS; Girotto GC; de la Fouchardiere C; Senellart H; van Laarhoven HWM; Mansoor W; Al-Rajabi R; Norquist J; Amonkar M; Suryawanshi S; Bhagia P; Metges JP
    J Clin Oncol; 2022 Feb; 40(4):382-391. PubMed ID: 34730989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation, validation of the EORTC esophageal cancer quality-of-life questionnaire for Japanese with esophageal squamous cell carcinoma: analysis in thoraco-laparoscopic esophagectomy versus open esophagectomy.
    Fujita T; Okada N; Sato T; Mayanagi S; Kanamori J; Daiko H
    Jpn J Clin Oncol; 2016 Jul; 46(7):615-21. PubMed ID: 27056967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary patterns and the risk of esophageal squamous cell carcinoma: A population-based case-control study in a rural population.
    Liu X; Wang X; Lin S; Lao X; Zhao J; Song Q; Su X; Tak-Sun Yu I
    Clin Nutr; 2017 Feb; 36(1):260-266. PubMed ID: 26687305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macronutrients, vitamins and minerals intake and risk of esophageal squamous cell carcinoma: a case-control study in Iran.
    Jessri M; Rashidkhani B; Hajizadeh B; Jessri M; Gotay C
    Nutr J; 2011 Dec; 10():137. PubMed ID: 22185224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative blood-routine markers and prognosis of esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study.
    Hu D; Lin X; Chen Y; Chang Q; Chen G; Li C; Zhang H; Cui Z; Liang B; Jiang W; Ji K; Huang J; Peng F; Zheng X; Niu W
    Oncotarget; 2017 Apr; 8(14):23841-23850. PubMed ID: 27852044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
    Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
    BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of EORTC QLQ-OES18 for Chinese patients with esophageal cancer.
    Dai Z; Lang W; Yang H; Tian J; Sun W; Pekbay B; Lin Y; Wang M; Cui B; Yang S; Li H; Luo L; Guo H; Zhang L
    Dis Esophagus; 2017 Oct; 30(10):1-7. PubMed ID: 28859386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.